(Q44254747)

1 December 2017

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients (English)

1 reference

1 December 2017

0 references

1 reference

Sangeeta M Bhorade

1

1 reference

1 December 2017

Nell S Lurain

2

1 reference

1 December 2017

Ashby Jordan

3

1 reference

1 December 2017

Julie Leischner

4

1 reference

1 December 2017

Jaime Villanueva

5

1 reference

1 December 2017

Ramon Durazo

6

1 reference

1 December 2017

Steve Creech

7

1 reference

1 December 2017

Wickii T Vigneswaran

8

1 reference

1 December 2017

Edward R Garrity

9

1 reference

1 December 2017

1 December 2002

1 reference

The Journal of Heart and Lung Transplantation

1 December 2017

1 reference

1 December 2017

21

1 reference

1 December 2017

12

1 reference

1 December 2017

1274-1282

1 reference

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Infection in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Ganciclovir resistance: a matter of time and titre

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Antiviral drug resistance in human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

Quantitation of human cytomegalovirus DNA in peripheral blood leukocytes of heart transplant recipients: relationship with pp65 antigenemia and with antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900463-1

7 January 2021

10.1016/S1053-2498(02)00463-1

Identifiers

DOI

1 reference

1 December 2017

1 reference